Au(I)-Catalyzed Cyclization of tert-Butyl Carbonates Derived from ­Homopropargyl Alcohols: A Catalytic Alternative to Cyclic Enol Carbonates

Abstract

Au(I)-complexes catalyze cyclization of tert-butyl ­carbonates derived from a variety of homopropargyl alcohols. This procedure offers a catalytic alternative to stoichiometric Lewis ­acids for the preparation of a range of enol carbonates.

gold catalysis - tert-butyl carbonate - homopropargyl ­alcohol - enol carbonate - ligand

References and Notes

For excellent reviews on recent advances in Au-catalysis, see:

1a Hashmi ASK. Gold Bull.  2004,  37:  51 

1b Hoffmann-Roder A. Krause N. Org. Biomol. Chem.  2005,  3:  387 

For more recent reports not cited in these reviews, see:

1c Hashmi ASK. Weyrauch JP. Frey W. Bats JW. Org. Lett.  2004,  6:  4391 

1d Zhang L. Kozmin SA. J. Am. Chem. Soc.  2004,  126:  6962 

1e Zhang L. Kozmin SA. J. Am. Chem. Soc.  2004,  126:  11806 

1f Hashmi ASK. Rudolph M. Weyrauch JP. Wolfle M. Frey W. Bats JW. Angew. Chem. Int. Ed.  2005,  44:  2798 

1g Shi X. Gorin DJ. Toste FD. J. Am. Chem. Soc.  2005,  127:  5802 

1h Nieto-Oberhuber C. Lopez S. Echavarren AM. J. Am. Chem. Soc.  2005,  127:  6178 

1i Markham JP. Staben ST. Toste FD. J. Am. Chem. Soc.  2005,  127:  9708 

1j Gorin DJ. Davies NR. Toste FD. J. Am. Chem. Soc.  2005,  127:  11260 

1k Asao N. Sato K. Menggenbateer . Yamamoto Y. J. Org. Chem.  2005,  70:  3682 

1l Sato K. Asao N. Yamamoto Y. J. Org. Chem.  2005,  70:  8977 

1m Kim N. Kim Y. Sung D. Gupta AK. Oh CH. Org. Lett.  2005,  7:  5289 

2 Maddess ML. Lautens M. Synthesis  2004,  1399 

3a Trost BM. Ball ZT. Joege T. Angew. Chem. Int. Ed.  2003,  42:  3415 

3b Davies HML. Beckwith RE. Antoulinakis EG. Jin Q. J. Org. Chem.  2003,  68:  6126 

3c Bode JW. Carreira EK. J. Org. Chem.  2001,  66:  6410 

3d Nelson SG. Wan Z. Org. Lett.  2000,  2:  1883 

3e Nelson SG. Zhu C. Shen X. J. Am. Chem. Soc.  2003,  126:  14 

Allyl or homoallyl carbonates:

4a Bartlett PA. Meadows JD. Brown EG. Morimoto A. Jernstedt KK. J. Org. Chem.  1982,  47:  4013 

4b Bongini A. Cardillo G. Orena M. Porzi G. Sandri S. J. Org. Chem.  1982,  47:  4626 

4c Duan JJ.-W. Smith AB. J. Org. Chem.  1993,  58:  3703 

4d Smith AB. Friestad GK. Barbosa J. Bertounesque E. Hull KG. Iwashima M. Qui Y. Salvatore BA. Spoors PG. Duan JJ.-W. J. Am. Chem. Soc.  1999,  121:  10468 

Propargyl carbonates:

4e Fournier J. Bruneau C. Dixneuf PH. Tetrahedron Lett.  1989,  30:  3981 

4f Inoue Y. Ohuchi K. Imaizumi S. Tetrahedron Lett.  1988,  29:  5941 

4g Iritani K. Yanagihara N. Utimoto K. J. Org. Chem.  1986,  51:  5501 

5a Marshall JA. J. Org. Chem.  1999,  64:  3798 

5b Raimundo BC. Heathcock CH. Org. Lett.  2000,  2:  27 

6a Trost BM. Science  1991,  254:  1471 

6b Trost BM. Angew. Chem., Int. Ed. Engl.  1995,  34:  259 

7

The β-hydroxyketone 3a is formed during the reaction, not during the subsequent workup. For example, upon a long-term storage of 2a, there was no change in the spectral integrity or in its TLC profile.

8 Typical side products formed at an early stage of the reaction and showed multiple non-polar spots in TLC, which could not be unambiguously identified. A similar observation was made by Gagosz: Gagosz F. Org. Lett.  2005,  7:  4129 

9a Kang JE. Lee ES. Park SI. Shin S. Tetrahedron Lett.  2005,  46:  7431 

9b Shin S. Bull. Korean Chem. Soc.  2005,  26:  1925 

10

Representative Procedure for the Cyclization of 1d into 2d.
To a solution of 1d (100 mg, 0.384 mmol) in 1,2-dichloro-ethane (2 mL) at 0 °C, was added Au(PAr₃)Cl (Ar = C₆F₅) (14.3 mg, 19.2 µmol), followed by AgSbF₆ (6.6 mg, 19.2 µmol). Upon addition of AgSbF₆, the color of the reaction mixture immediately turned to orange. The reaction mixture was kept at 0 °C for 15 h, then was slowly allowed to warm to r.t. over 5 h. After the reaction was judged to be complete by TLC, the crude mixture was concentrated to ca. 0.5 mL and was loaded on silica gel column and was eluted with EtOAc-hexane (1:4) to obtain 62.8 mg (80%) of 2d as pale yellow oil, along with 5.7 mg (8%) of hydrolyzed by-product, 3d.
For compound 2a see ref. 2.
Compound 2b: IR: 1777 cm^-1. ¹H NMR (400 MHz, CDCl₃): δ = 7.40 (d, J = 7.9 Hz, 2 H), 7.31 (d, J = 7.8 Hz, 2 H), 5.42 (dd, J = 3.3, 10.7 Hz, 1 H), 4.87 (dd, J = 1.5, 2.2 Hz, 1 H), 4.44 (app t, J = 1.8 Hz, 1 H), 2.93 (dd, J = 3.3, 15.4 Hz, 1 H), 2.76 (tdd, J = 1.5, 10.6, 15.4 Hz, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 150.8, 146.7, 135.9, 135.6, 129.9, 127.8, 95.8, 78.7, 33.8. MS (EI): m/z = 181 [M - CO₂ + H].
Compound 2c: IR: 1779 cm^-1. ¹H NMR (400 MHz, CDCl₃): δ = 7.33 (t, J = 7.7 Hz, 1 H), 6.94-6.88 (m, 3 H), 5.41 (dd, J = 3.3, 10.6 Hz, 1 H), 4.86 (app t, J = 1.8 Hz, 1 H), 4.42 (app t, J = 1.9 Hz, 1 H), 3.81 (s, 3 H), 2.93 (dd, J = 3.3, 15.4 Hz, 1 H), 2.79 (tdd, J = 1.9, 10.7, 15.4 Hz, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 160.0, 150.4, 146.3, 137.9, 130.0, 117.8, 114.7, 111.2, 94.8, 78.6, 55.3, 33.2.
Compound 2d: IR: 1780 cm^-1. ¹H NMR (400 MHz, CDCl₃): δ = 7.35-7.25 (m, 1 H), 7.24-7.12 (m, 3 H), 5.40 (dd, J = 3.3, 10.3 Hz, 1 H), 4.85 (app t, J = 2.2 Hz, 1 H), 4.42 (app t, J = 1.8 Hz, 1 H), 2.92 (dd, J = 3.2, 15.0 Hz, 1 H), 2.79 (tdd, J = 1.4, 10.6, 15.4 Hz, 1 H), 2.39 (s, 3 H). ¹³C NMR 100 MHz, CDCl₃): δ = 151.2, 147.1, 139.5, 137.1, 130.7, 129.5, 127.0, 123.4, 95.4, 79.5, 33.9, 22.1.
Compound 2e: IR: 1772 cm^-1. ¹H NMR (400 MHz, CDCl₃): δ = 4.77 (app t, J = 1.8 Hz, 1 H), 4.36 (app t, J = 1.4 Hz, 1 H), 4.15 (ddd, J = 2.3, 6.9, 10.2 Hz, 1 H), 2.65 (dd, J = 2.9, 15.0 Hz, 1 H), 2.50 (tdd, J = 1.5, 10.3, 15.0 Hz, 1 H), 2.00 (m, 1 H), 1.85-1.07 (m, 10 H). ¹³C NMR (100 MHz, CDCl₃): δ = 151.7, 147.4, 94.9, 82.6, 41.9, 29.1, 28.6, 28.4, 26.7, 26.3, 26.1.
Compound 2f: IR: 1772 cm^-1. ¹H NMR (400 MHz, CDCl₃): δ = 4.79 (t, J = 1.5 Hz, 1 H), 4.44 (m, 1 H), 4.37 (t, J = 1.5 Hz, 1 H), 2.70 (dd, J = 3.3, 15.4 Hz, 1 H), 2.46 (tdd, J = 1.5, 9.5, 15.0 Hz, 1 H), 1.77 (m, 1 H), 1.75-1.38 (m, 3 H), 0.97 (t, J = 7.3 Hz, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 151.4, 147.3, 95.0, 78.3, 37.0, 31.5, 18.5, 14.3.
Compound 2g: IR: 1775 cm^-1. ¹H NMR (400 MHz, CDCl₃): δ = 4.78 (t, J = 1.9 Hz, 1 H), 4.37 (t, J = 1.9 Hz, 1 H), 4.13 (ddd, J = 2.9, 6.6, 10.6 Hz, 1 H), 2.66 (dd, J = 3.0, 15.1 Hz, 1 H), 2.48 (tdd, J = 1.5, 10.6, 15.4 Hz, 1 H), 1.93 (m, 1 H), 1.05 (d, J = 7.0 Hz, 3 H), 0.99 (d, J = 7.0 Hz, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 151.6, 147.4, 94.9, 83.2, 32.5, 29.0, 18.2, 18.1.
Compound 2h: IR: 1772 cm^-1. ¹H NMR (400 MHz, CDCl₃): δ = 4.77 (dd, J = 0.7, 2.6 Hz, 1 H), 4.39 (dd, J = 1.4, 2.6 Hz, 1 H), 3.90 (dd, J = 4.4, 7.3 Hz, 1 H), 2.68 (m, 1 H), 1.92-1.52 (m, 7 H), 1.21 (d, J = 6.9 Hz, 3 H), 1.45-1.10 (m, 4 H). ¹³C NMR (100 MHz, CDCl₃): δ = 156.7, 147.3, 93.7, 87.2, 39.8, 32.0, 29.8, 26.6, 26.3, 14.5.
Compound 2i: IR: 1773 cm^-1. ¹H NMR (400 MHz, CDCl₃): δ = 4.80 (dd, J = 1.1, 2.6 Hz, 1 H), 4.40 (dd, J = 1.5, 2.6 Hz, 1 H), 4.10 (dt, J = 4.0, 8.1 Hz, 1 H), 2.52 (m, 1 H), 1.75-1.47 (m, 3 H), 1.47-1.20 (m, 9 H), 1.23 (d, J = 7.0 Hz, 3 H), 0.88 (t, J = 7.0 Hz, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 156.6, 147.1, 93.8, 83.3, 34.7, 33.6, 32.4, 29.9, 29.7, 24.8, 23.3, 14.8, 14.3.